The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Multifunctional Enveloped Mesoporous Silica Nanoparticles for Subcellular Co-delivery of Drug and Therapeutic Peptide
Open accessAbstract
A multifunctional enveloped nanodevice based on mesoporous silica nanoparticle (MSN) was delicately designed for subcellular co-delivery of drug and therapeutic peptide to tumor cells. Mesoporous silica MCM-41 nanoparticles were used as the core for loading antineoplastic drug topotecan (TPT). The surface of nanoparticles was decorated with mitochondria-targeted therapeutic agent (Tpep) containing triphenylphosphonium (TPP) and antibiotic peptide (KLAKLAK)2 via disulfide linkage, followed by coating with a charge reversal polyanion poly(ethylene glycol)-blocked-2,3-dimethylmaleic anhydride-modified poly(L-lysine) (PEG-PLL(DMA)) via electrostatic interaction. It was found that the outer shielding layer could be removed at acidic tumor microenvironment due to the degradation of DMA blocks and the cellular uptake was significantly enhanced by the formation of cationic nanoparticles. After endocytosis, due to the cleavage of disulfide bonds in the presence of intracellular glutathione (GSH), pharmacological agents (Tpep and TPT) could be released from the nanoparticles and subsequently induce specific damage of tumor cell mitochondria and nucleus respectively with remarkable synergistic antitumor effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Cited by
Delivering CRISPR: a review of the challenges and approaches
Lino, C. A., Harper, J. C., Carney, J. P., & Timlin, J. A. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1474964 · Cited by 1,185
Nanoarchitectured Structure and Surface Biofunctionality of Mesoporous Silica Nanoparticles
Kankala, R. K., Han, Y., Na, J., Lee, C., Sun, Z., Wang, S., Kimura, T., Ok, Y. S., Yamauchi, Y., Chen, A., et al. (2020) · Advanced Materials · doi:10.1002/adma.201907035 · Cited by 635
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
Vallet-Regí, M., Schüth, F., Lozano, D., Colilla, M., & Manzano, M. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00659b · Cited by 507
Gated Materials for On-Command Release of Guest Molecules
Aznar, E., Oroval, M., Pascual, L., Murguía, J. R., Martínez-Máñez, R., & Sancenón, F. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00456 · Cited by 488
Recent Advances in Subcellular Targeted Cancer Therapy Based on Functional Materials
Chen, W., Luo, G., & Zhang, X. (2019) · Advanced Materials · doi:10.1002/adma.201802725 · Cited by 373
Self-citationSilica Nanoparticles—A Versatile Tool for the Treatment of Bacterial Infections
Selvarajan, V., Obuobi, S., & Ee, P. L. R. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00602 · Cited by 315
Zhao, Y., Wang, Y., Ran, F., Cui, Y., Liu, C., Zhao, Q., Gao, Y., Wang, D., & Wang, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-03834-2 · Cited by 301
Glutathione responsive polymers and their application in drug delivery systems
Quinn, J. F., Whittaker, M. R., & Davis, T. P. (2017) · Polymer Chemistry · doi:10.1039/c6py01365a · Cited by 280
Biosafety of mesoporous silica nanoparticles; towards clinical translation
Lérida-Viso, A., Estepa-Fernández, A., García-Fernández, A., Martí-Centelles, V., & Martínez-Máñez, R. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115049 · Cited by 279
Janjua, T. I., Cao, Y., Kleitz, F., Linden, M., Yu, C., & Popat, A. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115115 · Cited by 259
Song, Y., Li, Y., Xu, Q., & Liu, Z. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s117495 · Cited by 258
Sol–Gel‐Based Advanced Porous Silica Materials for Biomedical Applications
Lei, Q., Guo, J., Noureddine, A., Wang, A., Wuttke, S., Brinker, C. J., & Zhu, W. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909539 · Cited by 254
Self-citationCheng, Y.-J., Luo, G.-F., Zhu, J.-Y., Xu, X.-D., Zeng, X., Cheng, D.-B., Li, Y.-M., Wu, Y., Zhang, X.-Z., Zhuo, R.-X., et al. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b00752 · Cited by 253
Self-citationAdvances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: An update
Castillo, R. R., Lozano, D., González, B., Manzano, M., Izquierdo-Barba, I., & Vallet-Regí, M. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1598375 · Cited by 197
Hybrid nanoparticles for combination therapy of cancer
He, C., Lu, J., & Lin, W. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.029 · Cited by 174
Cisplatin and doxorubicin dual-loaded mesoporous silica nanoparticles for controlled drug delivery
Li, H., Yu, H., Zhu, C., Hu, J., Du, M., Zhang, F., & Yang, D. (2016) · RSC Advances · doi:10.1039/c6ra17213j · Cited by 57
Metadata
- Authors
- Luo, G.-F., Chen, W.-H., Liu, Y., Lei, Q., Zhuo, R.-X., & Zhang, X.-Z.
- Venue
- Scientific Reports
- Published
- 2014-08-14
- Volume
- 4
- Issue
- 1
- Pages
- 6064-6064
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2012695162
- Cited by
- 167
- References
- 1
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.